Eben Tessari
Founder at KINIKSA PHARMACEUTICALS, LTD.
Net worth: 2 M $ as of 29/04/2024
Eben Tessari active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KINIKSA PHARMACEUTICALS, LTD. | Chief Operating Officer | 02/01/2022 | - |
| Founder | 30/06/2015 | - | |
| Corporate Officer/Principal | 30/06/2015 | 02/01/2022 |
Career history of Eben Tessari
Former positions of Eben Tessari
| Companies | Position | Start | End |
|---|---|---|---|
| SYNAGEVA BIOPHARMA CORP | Corporate Officer/Principal | 30/11/2014 | 30/06/2015 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Corporate Officer/Principal | 31/10/2013 | 30/11/2014 |
Training of Eben Tessari
| Northeastern University | Undergraduate Degree |
| Boston University | Graduate Degree |
| Suffolk University | Graduate Degree |
Statistics
International
| United States | 6 |
| Israel | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Graduate Degree | 2 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Synageva BioPharma Corp.
 Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Health Technology |
- Stock Market
- Insiders
- Eben Tessari
- Experience
